about
Haplotype and functional analysis of four flavin-containing monooxygenase isoform 2 (FMO2) polymorphisms in Hispanics.A meta-analysis of CYP2D6 metabolizer phenotype and metoprolol pharmacokineticsPharmacogenetic profile of xenobiotic enzyme metabolism in survivors of the Spanish toxic oil syndrome.Perioperative genomicsInfluence of phenylalanine-481 substitutions on the catalytic activity of cytochrome P450 2D6Pharmacogenetics: data, concepts and tools to improve drug discovery and drug treatment.Polymorphisms of xenobiotic-metabolizing enzymes and susceptibility to cancerDrug interactions between antiretroviral medications and medications used in the treatment of drug addiction: research needs.The association of CYP2D6 genotype and postoperative nausea and vomiting in orthopedic trauma patientsPharmacogenetics of CYP2C19: functional and clinical implications of a new variant CYP2C19*17CYP2D6 and CYP3A4 involvement in the primary oxidative metabolism of hydrocodone by human liver microsomes.Pharmacogenomic considerations in opioid analgesia.Genome-wide association studies in pharmacogenomics: successes and lessons.Cytochrome P450 2D6 variants in a Caucasian population: allele frequencies and phenotypic consequences.Genetic variation, β-blockers, and perioperative myocardial infarction.Relationship between proguanil metabolic ratio and CYP2C19 genotype in a Caucasian populationThe influence of CYP2B6, CYP2C9 and CYP2D6 genotypes on the formation of the potent antioestrogen Z-4-hydroxy-tamoxifen in human liver.CYP2D6, GST-M1 and GST-T1 enzymes: expression in parathyroid gland and association with the parathyroid hormone concentration during early renal replacement therapy.Effects of clarithromycin on lansoprazole pharmacokinetics between CYP2C19 genotypes.CYP2D6 polymorphism in a Gabonese population: contribution of the CYP2D6*2 and CYP2D6*17 alleles to the high prevalence of the intermediate metabolic phenotype.Phenotypes and genotypes for CYP2D6 and CYP2C19 in a black Tanzanian population.Frequencies of CYP2D6 mutant alleles in a normal Japanese population and metabolic activity of dextromethorphan O-demethylation in different CYP2D6 genotypesThe Human Cytochrome P450 (CYP) Allele Nomenclature website: a peer-reviewed database of CYP variants and their associated effects.Intestinal cytochromes P450 regulating the intestinal microbiota and its probiotic profile.Cytochrome P450 2D6 polymorphisms and predicted opioid metabolism in African American children with sickle cell disease.Genetic polymorphism of enzymes involved in xenobiotic metabolism and the risk of lung cancerCytochrome P450 2D6.Functional significance of a C-->A polymorphism in intron 1 of the cytochrome P450 CYP1A2 gene tested with caffeine.Effect of the CYP2D6*10 genotype on venlafaxine pharmacokinetics in healthy adult volunteers.Determinants of the substrate specificity of human cytochrome P-450 CYP2D6: design and construction of a mutant with testosterone hydroxylase activity.CYP2D6 genotyping as an alternative to phenotyping for determination of metabolic status in a clinical trial setting.Evidence that serine 304 is not a key ligand-binding residue in the active site of cytochrome P450 2D6.Polymorphisms in the cytochrome P450 CYP1A2 gene (CYP1A2) in colorectal cancer patients and controls: allele frequencies, linkage disequilibrium and influence on caffeine metabolism.Polymorphisms in drug-metabolizing enzymes: what is their clinical relevance and why do they exist?The Pharmacogene Variation (PharmVar) Consortium: Incorporation of the Human Cytochrome P450 (CYP) Allele Nomenclature Database.
P2860
Q24539077-CA491BA1-F5BE-427E-9BA5-3DA41780BDD6Q24602122-3CEE2A4E-7826-4D4F-A7FE-2B2F8201DBDDQ24812002-B502A8FC-06E8-438B-BD65-74C1FE2BA570Q26852636-0E380CC2-96F3-4ACE-BD2E-6AEC40F54BB4Q28361814-81E8B903-7536-425B-A715-3FFACB343E57Q31144283-67498755-7983-4B52-B9B2-865DF6A9189AQ33608783-C425F83E-7396-4B7E-ACFE-0DEBB16209A0Q33640426-BCE1FA37-7D00-4211-8A9B-D3C5536E7381Q33641660-72B4DAB2-94AE-4A89-9572-A56534C85F16Q33692784-497AAD36-F3F0-4D3D-93BE-23DB4754E08EQ34302849-036598E4-43BD-40B9-8DC7-B25ABBAA5BCDQ34316700-B1758817-8A4C-4306-B9EA-9B9BBCE91160Q34415006-2377A6AB-B8A3-41FF-828E-2184E55AF5F5Q35238375-8376F97F-1701-4295-92C2-44BDB00AB496Q35580952-E0A536D8-ACEE-481A-95EB-DA28F4AE8C16Q35802629-4002D31E-78D0-41E5-9447-B3FE0701F884Q35803966-88C1E7B0-89EF-4848-AC79-2D507717E49EQ35825603-C7324FDD-A5EA-47FA-9664-D970EA0C9AFFQ35826832-4E71D400-6D8A-41C8-8680-AF728BFD54EEQ36053309-96A2FD24-5B6F-4163-B735-9CD8DA388B82Q36053715-D0B3312D-E6A7-4D0D-9666-EC5A3A1B6159Q36055234-6473FD7B-8947-4388-B8F7-07E94D500C4BQ36475111-C2238C25-1251-439F-A244-9CBB2BC2AFD7Q37106018-0ACCFA45-C448-4E15-8D06-B90F4DA2337FQ37146879-E4BA9325-5043-4C55-B498-0A84295FB6B7Q37296120-64FF4C5A-79FE-4DFB-97B7-9733AE91270FQ37513508-9709F274-4728-4990-82E6-59F737153452Q41593416-462D9B07-337F-43D5-8F87-8498551D17FCQ41593701-B23CC8F6-4256-44C5-9BDC-4C4419D56558Q41806994-EC97A616-22D9-4C26-B4B0-3BA097122B9BQ41987357-D3FEF143-396F-4AAF-AA38-9F0871FDFB64Q42128776-C71A6500-2175-4CCC-9C44-02753B5D3B4AQ42284296-1C82A71F-75DE-476B-838C-3DAE4F153695Q43109060-D5EFDF85-7E0B-4C12-B8D2-F5A19AFA574DQ46086738-BD4BD4CC-63C6-4937-9AEC-5FCEE6DD21C4
P2860
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年学术文章
@wuu
1996年学术文章
@zh
1996年学术文章
@zh-cn
1996年学术文章
@zh-hans
1996年学术文章
@zh-my
1996年学术文章
@zh-sg
1996年學術文章
@yue
1996年學術文章
@zh-hant
name
Nomenclature for human CYP2D6 alleles.
@en
Nomenclature for human CYP2D6 alleles.
@nl
type
label
Nomenclature for human CYP2D6 alleles.
@en
Nomenclature for human CYP2D6 alleles.
@nl
prefLabel
Nomenclature for human CYP2D6 alleles.
@en
Nomenclature for human CYP2D6 alleles.
@nl
P2093
P1476
Nomenclature for human CYP2D6 alleles.
@en
P2093
Brockmöller J
Eichelbaum M
Gonzalez FJ
Ishizaki T
P304
P577
1996-06-01T00:00:00Z